Selectivity of microbial acyl-coa : cholesterol acyltransferase inhibitors toward isozymes

Selectivity of microbial acyl-coa : cholesterol acyltransferase inhibitors toward isozymes

Play all audios:

Loading...

ABSTRACT The selectivity of microbial inhibitors of acyl-CoA : cholesterol acyltransferase (ACAT) toward the two isozymes, ACAT1 and ACAT2, was assessed in cell-based assays. Purpactin A (IC50 values of ACAT1 _vs_. IC50 values of ACAT2; 2.5 μM _vs_. 1.5 μM), terpendole C (10 μM _vs_. 10 μM), glisoprenin A (4.3 μM _vs_. 10 μM), spylidone (25 μM _vs_. 5.0 μM) and synthetic CL-283,546 (0.1 μM _vs_. 0.09 μM) inhibited ACAT1 and ACAT2 to similar extents. Beauveriolides I (0.6 μM _vs_. 20 μM) and III (0.9 μM _vs_. >20 μM) inhibited ACAT1 rather selectively, while pyripyropenes A (>80 μM _vs_. 0.07 μM), B (48 μM _vs_. 2.0 μM), C (32 μM _vs_. 0.36 μM) and D (38 μM _vs_. 1.5 μM) showed selective inhibition against ACAT2. In particular, pyripyropene A was found to be the most selective ACAT2 inhibitor with a selective index of more than 1,000. SIMILAR CONTENT BEING VIEWED BY OTHERS MECHANISM OF ACTION FOR SMALL-MOLECULE INHIBITORS OF TRIACYLGLYCEROL SYNTHESIS Article Open access 29 May 2023 ACYLTRANSFERASE THAT CATALYSES THE CONDENSATION OF POLYKETIDE AND PEPTIDE MOIETIES OF GOADVIONIN HYBRID LIPOPEPTIDES Article 27 July 2020 CELLUDINONE C, A NEW DIHYDROISOBENZOFURAN ISOLATED FROM _TALAROMYCES CELLULOLYTICUS_ BF-0307 Article 14 November 2024 ARTICLE PDF REFERENCES * Roth BD . ACAT inhibitors: Evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents. _Drug Disc Today_ 3: 19–25 ( 1998) Article  CAS  Google Scholar  * Alegret M, Llaverias G, Silvestre JS . Acyl-coenzyme A : cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic agents. _Methods Find Clin Pharmacol_ 26: 563–586 ( 2004) Article  CAS  Google Scholar  * Chang CC, Huh HY, Cadigan KM, Chang TY . Molecular cloning and functional expression of human acyl-coenzyme A : cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. _J Biol Chem_ 268: 20747–20755 ( 1993) CAS  PubMed  Google Scholar  * Anderson RA, Joyce C, Davis M, Reagan JW, Clark M, Shelness GS, Rudel LL . Identification of a form of acyl-CoA : cholesterol acyltransferase specific to liver and intestine in nonhuman primates. _J Biol Chem_ 273: 26747–26754 ( 1998) Article  CAS  PubMed  Google Scholar  * Cases S, Novak S, Zheng YW, Myers HM, Lear SR, Sande E, Welch CB, Lusis AJ, Spencer TA, Krause BR, Erickson SK, Farese RV Jr . ACAT-2, a second mammalian acyl-CoA : cholesterol acyltransferase. Its cloning, expression, and characterization. _J Biol Chem_ 273: 26755–26764 ( 1998) Article  CAS  PubMed  Google Scholar  * Oelkers P, Behari A, Cromley D, Billheimer JT, Sturley SL . Characterization of two human genes encoding acyl coenzyme A : cholesterol acyltransferase-related enzymes. _J Biol Chem_ 273: 26765–26771 ( 1998) Article  CAS  PubMed  Google Scholar  * Parini P, Davis M, Lada AT, Erickson SK, Wright TL, Gustafsson U, Sahlin S, Einarsson C, Eriksson M, Angelin B, Tomoda H, Ōmura S, Willingham MC, Rudel LL . ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. _Circulation_ 110: 2017–2023 ( 2004) Article  CAS  PubMed  Google Scholar  * Giovannoni MP, Piaz VD, Vergelli C, Barlocco D . Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs. _Mini Rev Med Chem_ 3: 576–584 ( 2003) Article  CAS  PubMed  Google Scholar  * Lada AT, Davis M, Kent C, Chapman J, Tomoda H, Ōmura S, Rudel LL . Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. _J Lipid Res_ 45: 378–386 ( 2004) Article  CAS  PubMed  Google Scholar  * Ikenoya M, Yoshinaka Y, Kobayashi H, Kawamine K, Shibuya K, Sato F, Sawanobori K, Watanabe T, Miyazaki A . A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Atherosclerosis: in press ( 2006) * Ōmura S, Tomoda H, Kim YK, Nishida H, Pyripyropenes highly potent inhibitors of acyl-CoA: cholesterol acyltransferase produced by _Aspergillus fumigatus_. _J Antibiot_ 46: 1168–1169 ( 1993) Article  Google Scholar  * Tomoda H, Kim YK, Nishida H, Masuma R, Ōmura S . Pyripyropenes, novel inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Aspergillus fumigatus_. I. Production, isolation, and biological properties. _J Antibiot_ 47: 148–153 ( 1994) Article  CAS  Google Scholar  * Kim YK, Tomoda H, Nishida H, Sunazuka T, Obata R, Ōmura S . Pyripyropenes, novel inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Aspergillus fumigatus_. II. Structure elucidation of pyripyropenes A, B, C and D. _J Antibiot_ 47: 154–162 ( 1994) Article  CAS  Google Scholar  * Tomoda H, Nishida H, Masuma R, Cao J, Okuda S, Ōmura S . Purpactins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Penicillium purpurogenum_. I. Production, isolation and physico-chemical and biological properties. _J Antibiot_ 44: 136–143 ( 1991) Article  CAS  Google Scholar  * Nishida H, Tomoda H, Cao J, Okuda S, Ōmura S . Purpactins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Penicillium purpurogenum_. II. Structure elucidation of purpactins A, B and C. _J Antibiot_ 44: 144–151 ( 1991) Article  CAS  Google Scholar  * Tomoda H, Huang XH, Nishida H, Masuma R, Kim YK, Ōmura S . Glisoprenins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Gliocladium_ sp. FO-1513. I. Production, isolation and physico-chemical and biological properties. _J Antibiot_ 45: 1202–1206 ( 1992) Article  CAS  Google Scholar  * Nishida H, Huang XH, Tomoda H, Ōmura S . Glisoprenins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Gliocladium_ sp. FO-1513. II. Structure elucidation of glisoprenins A and B. _J Antibiot_ 45: 1669–1676 ( 1992) Article  CAS  Google Scholar  * Ghosh I, Kishi Y, Tomoda H, Ōmura S . Guse of achiral praseodymium shift reagent in predicting the complete stereostructure of glisoprenin A. _Org Lett_ 6: 4719–4722 ( 2004) Article  CAS  PubMed  Google Scholar  * Huang XH, Tomoda H, Nishida H, Masuma R, Ōmura S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. I. Production, isolation and biological properties. _J Antibiot_ 48: 1–4 ( 1995) Article  CAS  Google Scholar  * Huang XH, Nishida H, Tomoda H, Tabata N, Shiomi K, Yang DJ, Takayanagi H, Ōmura S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. II. Structure elucidation of terpendoles A, B, C and D. _J Antibiot_ 48: 5–11 ( 1995) Article  CAS  Google Scholar  * Tomoda H, Tabata N, Yang DJ, Takayanagi H, Ōmura S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. III. Production, isolation and structure elucidation of new components. _J Antibiot_ 48: 793–804 ( 1995) Article  CAS  Google Scholar  * Namatame I, Tomoda H, Si S, Yamaguchi Y, Masuma R, Ōmura S . Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by _Beauveria_ sp. FO-6979. _J Antibiot_ 52: 1–6 ( 1999) Article  CAS  Google Scholar  * Namatame I, Tomoda H, Tabata N, Si S, Ōmura S . Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid droplet formation in mouse macrophages. _J Antibiot_ 52: 7–12 ( 1999) Article  CAS  Google Scholar  * Matsuda D, Namatame I, Tomoda H, Kobayashi S, Zocher R, Kleinkauf H, Ōmura S . New beauveriolide produced by amino acid-supplemented fermentation of _Beauveria_ sp. FO-6979. _J Antibiot_ 57: 1–9 ( 2004) Article  CAS  Google Scholar  * Mochizuki K, Ohmori K, Tamura H, Shizuri H, Nishiyama S, Miyoshi E, Yamamura S . The structures of bioactive cyclodepsipeptides, beauveriolides I and II, metabolites of entomopathogenic fungi _Beauveria_ sp. _Bull Chem Soc Jpn_ 66: 3041–3046 ( 1993) Article  CAS  Google Scholar  * Tomoda H, Namatame I, Si S, Kawaguchi K, Masuma R, Namikoshi M, Ōmura S . Phenochalasins, inhibitors of lipid droplet formation in mouse macrophages, produced by _Phomopsis_ sp. FT-0211. _J Antibiot_ 52: 851–856 ( 1999) Article  CAS  Google Scholar  * Tomoda H, Namatame I, Tabata N, Kawaguchi K, Si S, Ōmura S . Structure elucidation of fungal phenochalasins, novel inhibitors of lipid droplet formation in mouse macrophages. _J Antibiot_ 52: 857–861 ( 1999) Article  CAS  Google Scholar  * Koyama N, Nagahiro T, Yamaguchi Y, Ohshiro T, Masuma R, Tomoda H, Ōmura S . Spylidone, a novel inhibitor of lipid droplet accumulation in mouse macrophages produced by _Phoma_ sp. FKI-1840. _J Antibiot_ 58: 338–345 ( 2005) Article  CAS  Google Scholar  * Uchida R, Kim YP, Namatame I, Tomoda H, Ōmura S . Sespendole, a new inhibitor of lipid droplet synthesis in macrophages, produced by _Pseudobotrytis terrestris_ FKA-25. _J Antibiot_ 59: 93–97 ( 2006) Article  CAS  Google Scholar  * Namatame I, Tomoda H, Matsuda D, Tabata N, Kobayashi S, Ōmura S . K97-0239A and B, new inhibitors of macrophage foam cell formation, produced by _Streptomyces_ sp. K97-0239. _Proc Japan Acad B_ 78: 45–50 ( 2002) Article  Google Scholar  * Namatame I, Tomoda H, Ishibashi S, Ōmura S . Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages. _Proc Natl Acad Sci USA_ 101: 737–742 ( 2004) Article  CAS  PubMed  PubMed Central  Google Scholar  * _Chem Eng News_ 18: 15 ( 2004) * Namatame I, Tomoda H, Arai H, Inoue K, Ōmura S . Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C. _J Biochem_ 25: 319–327 ( 1999) Article  Google Scholar  * Bligh EG, Dyer W . A rapid method of total lipid extraction and purification. _Can J Biochem Physiol_ 37: 911–917 ( 1959) Article  CAS  PubMed  Google Scholar  * Field FJ, Cooper AD, Erickson SK . Regulation of rabbit intestinal acyl coenzyme A-cholesterol acyltransferase _in vivo_ and _in vitro_. _Gastroenterology_ 83: 873–880 ( 1982) CAS  PubMed  Google Scholar  * Cho KH, An S, Lee WS, Paik YK, Kim YK, Jeong TS . Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation. _Biochem Biophys Res Commun_ 309: 864–872 ( 2003) Article  CAS  PubMed  Google Scholar  * Tomoda H, Namatame I, Ōmura S . Microbial metabolites with inhibitory activity against lipid metabolism. _Proc Japan Acad B_ 78: 217–240 ( 2002) Article  Google Scholar  * Kouri K, Lemmens M, Gruber RL . Beauvericin-induced channenls in ventricular myocytes and liposomes. _Biochim Biophys Acta_ 1609: 203–210 ( 2003) Article  CAS  PubMed  Google Scholar  * Jow GM, Chou CJ, Chen BF, Tsai JH . Beauvericin induces cytotoxic effects in human acute lympoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium. _Cancer Lett_ 216: 165–173 ( 2004) Article  CAS  PubMed  Google Scholar  * Fukuda T, Arai M, Yamaguchi Y, Masuma R, Tomoda H, Ōmura S . New beauvericins, potentiators of antifungal miconazole activity, produced by _Beauveria_ sp. FKI-1366. I. _Taxonomy, fermentation, isolation and biological properties, J Antibiot_ 57: 110–116 ( 2004) CAS  Google Scholar  * Lin S, Cheng D, Liu MS, Chen J, Chang TY . Human acyl-CoA : cholesterol acyltransferase-1 in the endoplasmic reticulum contains seven transmembarane domains. _J Biol Chem_ 274: 23276–23285 ( 1999) Article  CAS  PubMed  Google Scholar  * Joyce CW, Shelness GS, Davis MA, Lee RG, Skinner K, Anderson RA, Rudel LL . ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. _Mol Biol Cell_ 11: 3675–3687 ( 2000) Article  CAS  PubMed  PubMed Central  Google Scholar  * Guo ZY, Lin S, Heinen JA, Chang CC, Chang TY . The active site His-460 of Human acyl-coenzyme A : cholesterol acyltransferase 1 resides in a hitherto undisclosed transmembrane domain. _J Biol Chem_ 280: 37814–37826 ( 2005) Article  CAS  PubMed  Google Scholar  * Lin S, Lu X, Chang CC, Chang TY . Human acyl-coenzyme A : cholesterol acyltransferase expressed in Chinese hamuster ovary cells: Membrane topology and active site location. _Mol Biol Cell_ 14: 2447–2460 ( 2003) Article  CAS  PubMed  PubMed Central  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan Hiroshi Tomoda * Kitasato Institute for Life Sciences and Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan Taichi Ohshiro & Satoshi Ōmura * Atherosclerosis Research Program, Wake Forest University School of Medicine, Winston-Salem, 27157, NC, USA Lawrence L Rudel Authors * Taichi Ohshiro View author publications You can also search for this author inPubMed Google Scholar * Lawrence L Rudel View author publications You can also search for this author inPubMed Google Scholar * Satoshi Ōmura View author publications You can also search for this author inPubMed Google Scholar * Hiroshi Tomoda View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Hiroshi Tomoda. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Ohshiro, T., Rudel, L., Ōmura, S. _et al._ Selectivity of Microbial Acyl-CoA : cholesterol Acyltransferase Inhibitors toward Isozymes. _J Antibiot_ 60, 43–51 (2007). https://doi.org/10.1038/ja.2007.6 Download citation * Received: 12 September 2006 * Accepted: 21 December 2006 * Issue Date: 01 January 2007 * DOI: https://doi.org/10.1038/ja.2007.6 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * acyl-CoA : cholesterol acyltransferase * isozyme * microbial inhibitors * lipid droplet accumulation * pyripyropene * beauveriolide * atherosclerosis

ABSTRACT The selectivity of microbial inhibitors of acyl-CoA : cholesterol acyltransferase (ACAT) toward the two isozymes, ACAT1 and ACAT2, was assessed in cell-based assays. Purpactin A


(IC50 values of ACAT1 _vs_. IC50 values of ACAT2; 2.5 μM _vs_. 1.5 μM), terpendole C (10 μM _vs_. 10 μM), glisoprenin A (4.3 μM _vs_. 10 μM), spylidone (25 μM _vs_. 5.0 μM) and synthetic


CL-283,546 (0.1 μM _vs_. 0.09 μM) inhibited ACAT1 and ACAT2 to similar extents. Beauveriolides I (0.6 μM _vs_. 20 μM) and III (0.9 μM _vs_. >20 μM) inhibited ACAT1 rather selectively,


while pyripyropenes A (>80 μM _vs_. 0.07 μM), B (48 μM _vs_. 2.0 μM), C (32 μM _vs_. 0.36 μM) and D (38 μM _vs_. 1.5 μM) showed selective inhibition against ACAT2. In particular,


pyripyropene A was found to be the most selective ACAT2 inhibitor with a selective index of more than 1,000. SIMILAR CONTENT BEING VIEWED BY OTHERS MECHANISM OF ACTION FOR SMALL-MOLECULE


INHIBITORS OF TRIACYLGLYCEROL SYNTHESIS Article Open access 29 May 2023 ACYLTRANSFERASE THAT CATALYSES THE CONDENSATION OF POLYKETIDE AND PEPTIDE MOIETIES OF GOADVIONIN HYBRID LIPOPEPTIDES


Article 27 July 2020 CELLUDINONE C, A NEW DIHYDROISOBENZOFURAN ISOLATED FROM _TALAROMYCES CELLULOLYTICUS_ BF-0307 Article 14 November 2024 ARTICLE PDF REFERENCES * Roth BD . ACAT inhibitors:


Evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents. _Drug Disc Today_ 3: 19–25 ( 1998) Article  CAS  Google Scholar  * Alegret M, Llaverias G, Silvestre JS .


Acyl-coenzyme A : cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic agents. _Methods Find Clin Pharmacol_ 26: 563–586 ( 2004) Article  CAS  Google Scholar  *


Chang CC, Huh HY, Cadigan KM, Chang TY . Molecular cloning and functional expression of human acyl-coenzyme A : cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. _J


Biol Chem_ 268: 20747–20755 ( 1993) CAS  PubMed  Google Scholar  * Anderson RA, Joyce C, Davis M, Reagan JW, Clark M, Shelness GS, Rudel LL . Identification of a form of acyl-CoA :


cholesterol acyltransferase specific to liver and intestine in nonhuman primates. _J Biol Chem_ 273: 26747–26754 ( 1998) Article  CAS  PubMed  Google Scholar  * Cases S, Novak S, Zheng YW,


Myers HM, Lear SR, Sande E, Welch CB, Lusis AJ, Spencer TA, Krause BR, Erickson SK, Farese RV Jr . ACAT-2, a second mammalian acyl-CoA : cholesterol acyltransferase. Its cloning, expression,


and characterization. _J Biol Chem_ 273: 26755–26764 ( 1998) Article  CAS  PubMed  Google Scholar  * Oelkers P, Behari A, Cromley D, Billheimer JT, Sturley SL . Characterization of two


human genes encoding acyl coenzyme A : cholesterol acyltransferase-related enzymes. _J Biol Chem_ 273: 26765–26771 ( 1998) Article  CAS  PubMed  Google Scholar  * Parini P, Davis M, Lada AT,


Erickson SK, Wright TL, Gustafsson U, Sahlin S, Einarsson C, Eriksson M, Angelin B, Tomoda H, Ōmura S, Willingham MC, Rudel LL . ACAT2 is localized to hepatocytes and is the major


cholesterol-esterifying enzyme in human liver. _Circulation_ 110: 2017–2023 ( 2004) Article  CAS  PubMed  Google Scholar  * Giovannoni MP, Piaz VD, Vergelli C, Barlocco D . Selective ACAT


inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs. _Mini Rev Med Chem_ 3: 576–584 ( 2003) Article  CAS  PubMed  Google Scholar  * Lada AT, Davis M,


Kent C, Chapman J, Tomoda H, Ōmura S, Rudel LL . Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. _J Lipid


Res_ 45: 378–386 ( 2004) Article  CAS  PubMed  Google Scholar  * Ikenoya M, Yoshinaka Y, Kobayashi H, Kawamine K, Shibuya K, Sato F, Sawanobori K, Watanabe T, Miyazaki A . A selective ACAT-1


inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Atherosclerosis: in press ( 2006) * Ōmura S, Tomoda H, Kim YK, Nishida H,


Pyripyropenes highly potent inhibitors of acyl-CoA: cholesterol acyltransferase produced by _Aspergillus fumigatus_. _J Antibiot_ 46: 1168–1169 ( 1993) Article  Google Scholar  * Tomoda H,


Kim YK, Nishida H, Masuma R, Ōmura S . Pyripyropenes, novel inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Aspergillus fumigatus_. I. Production, isolation, and biological


properties. _J Antibiot_ 47: 148–153 ( 1994) Article  CAS  Google Scholar  * Kim YK, Tomoda H, Nishida H, Sunazuka T, Obata R, Ōmura S . Pyripyropenes, novel inhibitors of acyl-CoA :


cholesterol acyltransferase produced by _Aspergillus fumigatus_. II. Structure elucidation of pyripyropenes A, B, C and D. _J Antibiot_ 47: 154–162 ( 1994) Article  CAS  Google Scholar  *


Tomoda H, Nishida H, Masuma R, Cao J, Okuda S, Ōmura S . Purpactins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Penicillium purpurogenum_. I. Production, isolation


and physico-chemical and biological properties. _J Antibiot_ 44: 136–143 ( 1991) Article  CAS  Google Scholar  * Nishida H, Tomoda H, Cao J, Okuda S, Ōmura S . Purpactins, new inhibitors of


acyl-CoA : cholesterol acyltransferase produced by _Penicillium purpurogenum_. II. Structure elucidation of purpactins A, B and C. _J Antibiot_ 44: 144–151 ( 1991) Article  CAS  Google


Scholar  * Tomoda H, Huang XH, Nishida H, Masuma R, Kim YK, Ōmura S . Glisoprenins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Gliocladium_ sp. FO-1513. I.


Production, isolation and physico-chemical and biological properties. _J Antibiot_ 45: 1202–1206 ( 1992) Article  CAS  Google Scholar  * Nishida H, Huang XH, Tomoda H, Ōmura S .


Glisoprenins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Gliocladium_ sp. FO-1513. II. Structure elucidation of glisoprenins A and B. _J Antibiot_ 45: 1669–1676 (


1992) Article  CAS  Google Scholar  * Ghosh I, Kishi Y, Tomoda H, Ōmura S . Guse of achiral praseodymium shift reagent in predicting the complete stereostructure of glisoprenin A. _Org Lett_


6: 4719–4722 ( 2004) Article  CAS  PubMed  Google Scholar  * Huang XH, Tomoda H, Nishida H, Masuma R, Ōmura S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. I.


Production, isolation and biological properties. _J Antibiot_ 48: 1–4 ( 1995) Article  CAS  Google Scholar  * Huang XH, Nishida H, Tomoda H, Tabata N, Shiomi K, Yang DJ, Takayanagi H, Ōmura


S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. II. Structure elucidation of terpendoles A, B, C and D. _J Antibiot_ 48: 5–11 ( 1995) Article  CAS  Google


Scholar  * Tomoda H, Tabata N, Yang DJ, Takayanagi H, Ōmura S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. III. Production, isolation and structure


elucidation of new components. _J Antibiot_ 48: 793–804 ( 1995) Article  CAS  Google Scholar  * Namatame I, Tomoda H, Si S, Yamaguchi Y, Masuma R, Ōmura S . Beauveriolides, specific


inhibitors of lipid droplet formation in mouse macrophages, produced by _Beauveria_ sp. FO-6979. _J Antibiot_ 52: 1–6 ( 1999) Article  CAS  Google Scholar  * Namatame I, Tomoda H, Tabata N,


Si S, Ōmura S . Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid droplet formation in mouse macrophages. _J Antibiot_ 52: 7–12 ( 1999) Article  CAS  Google


Scholar  * Matsuda D, Namatame I, Tomoda H, Kobayashi S, Zocher R, Kleinkauf H, Ōmura S . New beauveriolide produced by amino acid-supplemented fermentation of _Beauveria_ sp. FO-6979. _J


Antibiot_ 57: 1–9 ( 2004) Article  CAS  Google Scholar  * Mochizuki K, Ohmori K, Tamura H, Shizuri H, Nishiyama S, Miyoshi E, Yamamura S . The structures of bioactive cyclodepsipeptides,


beauveriolides I and II, metabolites of entomopathogenic fungi _Beauveria_ sp. _Bull Chem Soc Jpn_ 66: 3041–3046 ( 1993) Article  CAS  Google Scholar  * Tomoda H, Namatame I, Si S, Kawaguchi


K, Masuma R, Namikoshi M, Ōmura S . Phenochalasins, inhibitors of lipid droplet formation in mouse macrophages, produced by _Phomopsis_ sp. FT-0211. _J Antibiot_ 52: 851–856 ( 1999) Article


  CAS  Google Scholar  * Tomoda H, Namatame I, Tabata N, Kawaguchi K, Si S, Ōmura S . Structure elucidation of fungal phenochalasins, novel inhibitors of lipid droplet formation in mouse


macrophages. _J Antibiot_ 52: 857–861 ( 1999) Article  CAS  Google Scholar  * Koyama N, Nagahiro T, Yamaguchi Y, Ohshiro T, Masuma R, Tomoda H, Ōmura S . Spylidone, a novel inhibitor of


lipid droplet accumulation in mouse macrophages produced by _Phoma_ sp. FKI-1840. _J Antibiot_ 58: 338–345 ( 2005) Article  CAS  Google Scholar  * Uchida R, Kim YP, Namatame I, Tomoda H,


Ōmura S . Sespendole, a new inhibitor of lipid droplet synthesis in macrophages, produced by _Pseudobotrytis terrestris_ FKA-25. _J Antibiot_ 59: 93–97 ( 2006) Article  CAS  Google Scholar 


* Namatame I, Tomoda H, Matsuda D, Tabata N, Kobayashi S, Ōmura S . K97-0239A and B, new inhibitors of macrophage foam cell formation, produced by _Streptomyces_ sp. K97-0239. _Proc Japan


Acad B_ 78: 45–50 ( 2002) Article  Google Scholar  * Namatame I, Tomoda H, Ishibashi S, Ōmura S . Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation


in macrophages. _Proc Natl Acad Sci USA_ 101: 737–742 ( 2004) Article  CAS  PubMed  PubMed Central  Google Scholar  * _Chem Eng News_ 18: 15 ( 2004) * Namatame I, Tomoda H, Arai H, Inoue K,


Ōmura S . Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C. _J Biochem_ 25: 319–327 ( 1999) Article  Google Scholar  * Bligh EG, Dyer W . A rapid method of


total lipid extraction and purification. _Can J Biochem Physiol_ 37: 911–917 ( 1959) Article  CAS  PubMed  Google Scholar  * Field FJ, Cooper AD, Erickson SK . Regulation of rabbit


intestinal acyl coenzyme A-cholesterol acyltransferase _in vivo_ and _in vitro_. _Gastroenterology_ 83: 873–880 ( 1982) CAS  PubMed  Google Scholar  * Cho KH, An S, Lee WS, Paik YK, Kim YK,


Jeong TS . Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation. _Biochem Biophys Res Commun_ 309:


864–872 ( 2003) Article  CAS  PubMed  Google Scholar  * Tomoda H, Namatame I, Ōmura S . Microbial metabolites with inhibitory activity against lipid metabolism. _Proc Japan Acad B_ 78:


217–240 ( 2002) Article  Google Scholar  * Kouri K, Lemmens M, Gruber RL . Beauvericin-induced channenls in ventricular myocytes and liposomes. _Biochim Biophys Acta_ 1609: 203–210 ( 2003)


Article  CAS  PubMed  Google Scholar  * Jow GM, Chou CJ, Chen BF, Tsai JH . Beauvericin induces cytotoxic effects in human acute lympoblastic leukemia cells through cytochrome c release,


caspase 3 activation: the causative role of calcium. _Cancer Lett_ 216: 165–173 ( 2004) Article  CAS  PubMed  Google Scholar  * Fukuda T, Arai M, Yamaguchi Y, Masuma R, Tomoda H, Ōmura S .


New beauvericins, potentiators of antifungal miconazole activity, produced by _Beauveria_ sp. FKI-1366. I. _Taxonomy, fermentation, isolation and biological properties, J Antibiot_ 57:


110–116 ( 2004) CAS  Google Scholar  * Lin S, Cheng D, Liu MS, Chen J, Chang TY . Human acyl-CoA : cholesterol acyltransferase-1 in the endoplasmic reticulum contains seven transmembarane


domains. _J Biol Chem_ 274: 23276–23285 ( 1999) Article  CAS  PubMed  Google Scholar  * Joyce CW, Shelness GS, Davis MA, Lee RG, Skinner K, Anderson RA, Rudel LL . ACAT1 and ACAT2 membrane


topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. _Mol Biol Cell_ 11: 3675–3687 ( 2000) Article  CAS  PubMed  PubMed


Central  Google Scholar  * Guo ZY, Lin S, Heinen JA, Chang CC, Chang TY . The active site His-460 of Human acyl-coenzyme A : cholesterol acyltransferase 1 resides in a hitherto undisclosed


transmembrane domain. _J Biol Chem_ 280: 37814–37826 ( 2005) Article  CAS  PubMed  Google Scholar  * Lin S, Lu X, Chang CC, Chang TY . Human acyl-coenzyme A : cholesterol acyltransferase


expressed in Chinese hamuster ovary cells: Membrane topology and active site location. _Mol Biol Cell_ 14: 2447–2460 ( 2003) Article  CAS  PubMed  PubMed Central  Google Scholar  Download


references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan Hiroshi Tomoda * Kitasato Institute for


Life Sciences and Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan Taichi Ohshiro & Satoshi Ōmura * Atherosclerosis


Research Program, Wake Forest University School of Medicine, Winston-Salem, 27157, NC, USA Lawrence L Rudel Authors * Taichi Ohshiro View author publications You can also search for this


author inPubMed Google Scholar * Lawrence L Rudel View author publications You can also search for this author inPubMed Google Scholar * Satoshi Ōmura View author publications You can also


search for this author inPubMed Google Scholar * Hiroshi Tomoda View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to


Hiroshi Tomoda. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Ohshiro, T., Rudel, L., Ōmura, S. _et al._ Selectivity of Microbial Acyl-CoA :


cholesterol Acyltransferase Inhibitors toward Isozymes. _J Antibiot_ 60, 43–51 (2007). https://doi.org/10.1038/ja.2007.6 Download citation * Received: 12 September 2006 * Accepted: 21


December 2006 * Issue Date: 01 January 2007 * DOI: https://doi.org/10.1038/ja.2007.6 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get


shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * acyl-CoA


: cholesterol acyltransferase * isozyme * microbial inhibitors * lipid droplet accumulation * pyripyropene * beauveriolide * atherosclerosis